desipramine has been researched along with Addison's Disease in 1 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fehm, HL | 1 |
| Steck, R | 1 |
| Hohnloser, J | 1 |
| Voigt, KH | 1 |
| Pfeiffer, EF | 1 |
1 other study available for desipramine and Addison's Disease
| Article | Year |
|---|---|
Influence of neuroactive drugs on corticosteroid feedback regulation of ACTH secretion in man.
Topics: Addison Disease; Adrenal Cortex Hormones; Adrenalectomy; Adrenocorticotropic Hormone; Cushing Syndro | 1983 |